Granulomatosis with polyangiitis secondary prevention: Difference between revisions
Matt Pijoan (talk | contribs) (moved Wegener's granulomatosis secondary prevention to Wegeners granulomatosis secondary prevention) |
No edit summary |
||
Line 1: | Line 1: | ||
{{Wegener's granulomatosis}} | |||
Please help WikiDoc by adding content here. It's easy! Click [[Help:How_to_Edit_a_Page|here]] to learn about editing. | |||
{{CMG}}; '''Associate Editor-In-Chief:''' {{CZ}} | |||
==Overview== | |||
==Secondary Prevention== | |||
General well-being and laboratory organ markers are checked on a regular basis to ascertain the patient has remained in remission. | |||
==References== | |||
{{Reflist|2}} | |||
[[fr:Granulomatose de Wegener]] | |||
[[ja:ウェゲナー肉芽腫症]] | |||
[[pt:Granulomatose de Wegener]] | |||
{{WikiDoc Help Menu}} | |||
{{WikiDoc Sources}} | |||
[[Category:Needs content]] |
Revision as of 19:10, 28 September 2012
Granulomatosis with polyangiitis Microchapters |
Differentiating Granulomatosis with polyangiitis from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Granulomatosis with polyangiitis secondary prevention On the Web |
American Roentgen Ray Society Images of Granulomatosis with polyangiitis secondary prevention |
FDA on Granulomatosis with polyangiitis secondary prevention |
CDC on Granulomatosis with polyangiitis secondary prevention |
Granulomatosis with polyangiitis secondary prevention in the news |
Blogs on Granulomatosis with polyangiitis secondary prevention |
Directions to Hospitals Treating Granulomatosis with polyangiitis |
Risk calculators and risk factors for Granulomatosis with polyangiitis secondary prevention |
Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]
Overview
Secondary Prevention
General well-being and laboratory organ markers are checked on a regular basis to ascertain the patient has remained in remission.